Basal & Squamous Cell Skin Cancers in Adults

We established one of the first treatment programs in the New York City area for basal and squamous cell cancers, also called nonmelanoma skin cancers. Our dermatologists’ expertise in identifying and removing precancerous growths helps prevent many of these skin cancers from developing. When cancer is diagnosed, our medical oncologists, surgical oncologists, and radiation oncologists work together to provide the most effective treatment. Our reconstructive surgeons and rehabilitation doctors may also play an important role in your care.

Clinical Trials and Research Studies

Phase 2

A Phase II Open Label Randomized Study of Poly-ICLC Matured DC as an Adjuvant for NY-ESO-1 and Melan-A/MART-1 Peptide Vaccination Compared to Montanide ISA-51 VG in Study Subjects With Melanoma in Complete Clinical Remission But at High Risk of Disease Recurrence

Phase 3

A Phase 3 Randomized Study of Adjuvant Immunotherapy with Nivolumab Combined with Ipilimumab Versus Ipilimumab or Nivolumab Monotherapy after Complete Resection of Stage IIIb/c/d or Stage IV Melanoma

Phase 2

A Phase 2 Study Of Glembatumumab Vedotin an Anti-gpNMB Antibody-Drug Conjugate as Monotherapy or in Combination with Varlilumab In Patients with Advanced Melanoma

Phase 1

A Multicenter Open-Label Phase 1b Clinical Study of CMP-001 in Combination with Pembrolizumab in Subjects with Advanced Melanoma